Stryker Corporation (NYSE:SYK) Given Average Recommendation of “Moderate Buy” by Brokerages

Stryker Corporation (NYSE:SYK) has been given an average recommendation of “Moderate Buy” by the nineteen ratings firms that are covering the stock, Marketbeat.com reports. Five equities research analysts have rated the stock with a hold recommendation and fourteen have assigned a buy recommendation to the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $427.50.

A number of equities research analysts have recently issued reports on SYK shares. Truist Financial dropped their price target on Stryker from $400.00 to $392.00 and set a “hold” rating for the company in a research report on Thursday, December 18th. Evercore set a $390.00 price objective on Stryker in a research report on Monday, January 5th. Needham & Company LLC boosted their price objective on Stryker from $448.00 to $454.00 and gave the stock a “buy” rating in a research note on Friday, January 30th. TD Cowen cut Stryker from a “buy” rating to a “hold” rating and set a $387.00 target price for the company. in a report on Monday, January 26th. Finally, Raymond James Financial raised Stryker from a “market perform” rating to an “outperform” rating and set a $418.00 target price for the company in a research note on Tuesday, January 6th.

Insider Transactions at Stryker

In other Stryker news, Director Ronda E. Stryker sold 250,000 shares of Stryker stock in a transaction dated Wednesday, February 4th. The shares were sold at an average price of $362.92, for a total transaction of $90,730,000.00. Following the transaction, the director directly owned 2,457,331 shares of the company’s stock, valued at $891,814,566.52. The trade was a 9.23% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 5.20% of the company’s stock.

Institutional Trading of Stryker

Several hedge funds have recently made changes to their positions in the company. Clayton Financial Group LLC purchased a new stake in shares of Stryker during the 3rd quarter valued at approximately $26,000. Godfrey Financial Associates Inc. purchased a new position in Stryker in the fourth quarter worth approximately $26,000. Sankala Group LLC acquired a new stake in Stryker during the fourth quarter worth $26,000. United Financial Planning Group LLC acquired a new stake in Stryker during the third quarter worth $27,000. Finally, Atlas Capital Advisors Inc. purchased a new stake in Stryker in the fourth quarter valued at $27,000. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Stryker Stock Performance

NYSE:SYK opened at $332.48 on Tuesday. The company has a market cap of $127.24 billion, a P/E ratio of 39.58, a P/E/G ratio of 1.96 and a beta of 0.85. Stryker has a twelve month low of $328.23 and a twelve month high of $404.87. The company’s 50-day moving average price is $362.68 and its 200-day moving average price is $365.29. The company has a current ratio of 1.89, a quick ratio of 1.21 and a debt-to-equity ratio of 0.66.

Stryker (NYSE:SYK) last announced its quarterly earnings data on Thursday, January 29th. The medical technology company reported $4.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.40 by $0.07. The company had revenue of $7.17 billion during the quarter, compared to analysts’ expectations of $7.12 billion. Stryker had a net margin of 12.92% and a return on equity of 24.41%. Stryker’s revenue was up 11.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $4.01 EPS. On average, sell-side analysts forecast that Stryker will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 30th. Investors of record on Tuesday, March 31st will be issued a $0.88 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.1%. Stryker’s dividend payout ratio is currently 41.90%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.